As of 3:06pm ET
| -0.10 / -2.67%|
The 3 analysts offering 12-month price forecasts for Adamis Pharmaceuticals Corp have a median target of 6.25, with a high estimate of 6.40 and a low estimate of 5.00. The median estimate represents a +71.23% increase from the last price of 3.65.
The current consensus among 3 polled investment analysts is to Buy stock in Adamis Pharmaceuticals Corp. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.